RxDoctor Payments Data

Stacey Clancy, MD

Obstetrics & Gynecology · St Louis, MONPI 1649372202

Payments from drug & device makers

$2,246in general payments, 2019–2025

Across 124 payments — averaging $18.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Organon$199
  • Astellas Pharma US Inc$132
  • Pfizer$64
  • Hologic Sales And Service, LLC$64
  • Agile Therapeutics, Inc.$35
  • plus $124 from 8 others

What the payments were for

  • Food & beverage$2,246100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)88$1,627
Organon12$199
Astellas Pharma US Inc7$132
Pfizer4$64
Hologic Sales And Service, LLC3$64
Agile Therapeutics, Inc.2$35
Johnson & Johnson1$19
Avion Pharmaceuticals1$17
Bayer1$16
Exact Sciences1$16
Meditrina1$15
Merck1$14
Exeltis, USA Inc.1$14
Optumhealth Care Solutions, LLC1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,246 in reported general payments places this provider in the 75th percentile of 750 obstetrics & gynecology providers in Missouri.

See all obstetrics & gynecology providers in Missouri

Medicare billing

Part B allowed, 2024
$9,269
Medicare patients
83
Services billed
131

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol36$2,008
ValacyclovirValacyclovir Hcl15$708
ProgesteroneProgesterone, Micronized12$633
Clobetasol Propionate25$589
Raloxifene Hcl12$323
Alendronate Sodium37$282
Venlafaxine Hcl ErVenlafaxine Hcl14$263

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in St Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →